Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00851747 · ClinicalTrials.gov registry record · NA
A Study of the Efficacy of Subcutaneous Phosphatidylcholine and Deoxycholate Injections for Localized Fat Removal
A NA study, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT00851747 is a NA study that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 18 participants.
The verdict
NCT00851747, a NA study, was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The primary objective of this study is to determine the efficacy of phosphatidylcholine and deoxycholate subcutaneous injections for localized fat removal. Subcutaneous injections of the study drug will be efficacious in decreasing localized fat deposits due to the known fat necrosis effects on fat tissue after study drug tissue incubation.
Interventions
- DRUG Saline
- DRUG Phosphatidylcholine Deoxycholate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2009-02 |
| Est. Completion | 2009-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00851747
The ClinicalTrials.gov registry entry for NCT00851747 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Saline is the first listed.
NCT00851747 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00851747 about?
NCT00851747 is a clinical study titled "A Study of the Efficacy of Subcutaneous Phosphatidylcholine and Deoxycholate Injections for Localized Fat Removal". The primary objective of this study is to determine the efficacy of phosphatidylcholine and deoxycholate subcutaneous injections for localized fat removal. Subcutaneous injections of the study drug will be efficacious in decreasing localized fat deposits due to the known fat necrosis effects on fat...
What is the current status of trial NCT00851747?
This trial is currently terminated. It is a NA study. The enrollment target is 18 participants. The study started on 2009-02. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00851747?
The interventions under investigation include: Saline (DRUG), Phosphatidylcholine Deoxycholate (DRUG).
Who is sponsoring clinical trial NCT00851747?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.